The Strategic CRISPR & Gene Editing Technology ETF (XDNA) is an international index fund from (United States) with a market capitalization of $ 2.58 M.
The current price of XDNA is $ 0.00, and its performance over the last 12 months was 0.00%. Investors who bought this ETF a year ago achieved a return of 0%.
Investing in Strategic CRISPR & Gene Editing Technology ETF can be done through brokerages with access to the international market or, when available, via BDRs in Brazil.